Merck & Co., Inc. $MRK Stock Position Increased by Fifth Third Wealth Advisors LLCDefense World · 10 hr ago
AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's?24/7 Wall Street · 23 hr ago
Merck CEO on melanoma vaccine results: The prescribing community will find results quite meaningfulCNBC Television · 1 day ago
Doctors call Moderna, Merck's cancer vaccine data a major advancement — even as stocks fallCNBC · 1 day ago
Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip24/7 Wall Street · 1 day ago
Merck & Co., Inc. $MRK Stock Position Increased by Brookstone Capital ManagementDefense World · 1 day agoMerck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 4, 2026 | -$0.27 | -$0.13 | Beat |
| Apr 30, 2026 | -$1.47 | -$1.28 | Beat |
| Feb 3, 2026 | $2.01 | $2.04 | Beat |
| Oct 30, 2025 | $2.36 | $2.58 | Beat |
| Jul 29, 2025 | $2.03 | $2.13 | Beat |
| Apr 24, 2025 | $2.13 | $2.22 | Beat |